Steep Hill Inc.

Equities

STPH

CA85832P2089

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 07:59:59 16/07/2024 pm IST			5-day change	1st Jan Change
0.03 ^CAD	0.00%		+20.00%	-14.29%

30/05	Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Canbud Distribution Corporation Signs a Letter of Intent with Hempsana Inc

January 19, 2021 at 06:21 pm IST

Canbud Distribution Corporation announced it has signed a Letter of Intent with Hempsana Inc. to develop and manufacture CBD products for distribution to the medical-patient channel.

Latest news about Steep Hill Inc.

Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05	CI
Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11	CI
Steep Hill Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Steep Hill Inc. Announces Demise of Director, David Walters	05/23/05	CI
Steep Hill Inc. Announces Chief Financial Officer Change	03/23/03	CI
Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	31/23/31	CI
Steep Hill Inc. Auditor Raises 'Going Concern' Doubt	01/23/01	CI
Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Steep Hill Inc. Enters into a Settlement and Release Agreement	02/23/02	CI
Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
Steep Hill Inc. to Close Canadian Lab and Focus on US Operations	02/22/02	CI
Steep Hill Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	20/22/20	CI
Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	31/22/31	CI
Steep Hill Michigan Achieves ISO 17025:2017 Accreditation	18/22/18	CI
Steep Hill Inc. Enters into A Licensing Agreement with SH Lab Holdings LLC, Expanding Its Network of Licensees to the State of Vermont	06/22/06	CI
Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	03/22/03	CI
Steep Hill Inc. Auditor Raises 'Going Concern' Doubt	02/22/02	CI
Steep Hill Inc. will Change its Ticker to STPH from CBDX	28/22/28	CI
Canbud Distribution Corp. will Change its Name to Steep Hill Inc	28/22/28	CI
Canbud Distribution Corporation will Change its Ticker to STPH from CBDX	28/22/28	CI
Canbud Distribution Corporation will Change its Name to Steep Hill Inc	28/22/28	CI
Canbud CEO Departs, Replacement Named	01/22/01	MT
Canbud Distribution Corporation Announces Executive Changes	01/22/01	CI
Canbud Distribution Corporation Announces Directorate Changes	01/22/01	CI

Chart Steep Hill Inc.

Duration

Period

More charts

Company Profile

Steep Hill Inc. is a Canada-based company. The Company is engaged in the process of restructuring its business and is exploring strategic alternatives.

Sector

Pharmaceuticals

Calendar

16/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
STEEP HILL INC.	-14.29%	355K
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.81B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.6B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.09B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.27B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.82B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.41B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.38B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.37B

Alternative Medicine